Acrivon Therapeutics Inc.

01/08/2026 | Press release | Distributed by Public on 01/09/2026 03:14

Presentation (8ea1462c a9cb 4560 a201 767eaadb1818)

Acrivon Therapeutics Inc. published this content on January 08, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on January 09, 2026 at 09:14 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]